Licensing Publicly Funded Knowledge: Seeking a Socially Sustainable Balance

Loading Map....

Date(s) - 05/11/2019
16:00 CET - 17:30 CET

Utrecht University, Library


The Netherlands has been a pioneer in addressing the shortcomings of the current R&D model and exploring possible alternative innovation mechanisms. However, research originating in Dutch public research institutions has been used to develop medicines with huge price tags.

Health Action International, Wemos and Utrecht University will hold an event to bring together representatives from government and academia to discuss latest reports and tools on the issue, and how to ensure the guidelines they contain are made operational and embraced by all stakeholders for the benefit of patients.

Follow along on Twitter:

Couldn’t watch our event ‘Licensing Publicly Funded Knowledge’ at @UtrechtUni this afternoon? Head to to rewatch the #FacebookLive event! #license2innovate

Thanks to @ellenthoen for a pertinent intervention: 'We need to start transforming these norms around socially sustainable licences into rules: it's hard to drive a hard bargain when the EU's rules show the private sector that actually, the sky is the limit.' #license2innovate

Victoria Defelippe @UAEMNL explains UAEM's university score card which marks each institution's medicial licensing practices on
#license2innovate #access2medicines #innovation

Joining our panellists @MiedemaF @EllaWeggen @OnadaExpansiva on stage for a roundtable discussion are @andrebroek, Jennifer Sellin of @MaastrichtU, and Victoria Defelippe, President @UAEMNL. Send us your questions using #license2innovate!

'We cannot forget that the Government needs to play an active role in ensuring public return on public investment'. Jennifer Sellin of @MaastrichtU contributing her perspective. #license2innovate #sociallicensing #access2medicines #publiclyfunded #clinicaltrials

Load More...